Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT04722341
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Time-Restricted Eating (TRE) — BEHAVIORAL8-hour daily eating period, starting 1-3 hours after waking up
- Control — BEHAVIORALMore than equal to a 12-hour daily eating period
Study Details
The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.
Key Dates
- Start date
- Jan 1, 2022
- Status verified
- Apr 2025
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 175 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Time-Restricted Eating (TRE)8-hour daily eating period. Participants eating window must start within 2 hours of waking up and no later than 9 am.
- Active Comparator: ControlMore than equal to a 12-hour daily eating period
Primary Outcome Measure
Pathologic Complete Response (pCR) and Organ Preservation Rate [ Time Frame: at end of 6-month intervention ]
Central Contacts
- Nathalie Nguyen, MPH310.423.4209
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | Alabama | 35294 | Courtney M Peterson, PhD Courtney M Peterson, PhD (PRINCIPAL_INVESTIGATOR) |
| Cedars-Sinai Medical Center | West Hollywood | California | 90048 | Nathalie Nguyen, MPH |
Find similar trials in Birmingham, AL
By condition
By specialty
Related Studies
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California
- Magnetic Resonance Imaging of Breast CancerRecruiting · Stanford University · Stanford, California
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona